Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company
Pressmeddelande. 31 januari 2018. Immunicum rekryterar Michaela Gertz som ny CFO . Immunicum AB (publ; Nasdaq Stockholm: IMMU.ST), ett bioteknikbolag som utvecklar nya immunostimulerande cancerbehandlingar för ett antal solida tumörformer, meddelar idag att Michaela Gertz börjar på bolaget som CFO från och med den 1 februari 2018.
Immunicum shareholders can request a printed Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session. Sijme Zeilemaker, M.Sc., Head of Investor Relations and Corporate Communication Telefon: +46 8 732 8400 E-post: ir@immunicum.com. Media Relations. Eva Mulder and Sophia Hergenhan, Ph.D.
About Immunicum AB (publ) E-mail: info@immunicum.com. Investor Relations. Sijme Zeilemaker Head of Investor Relations & Corporate Communication Telephone: +46 8 732 8400 E-mail: ir@immunicum.com. Media Relations E-mail: info@immunicum.com.
E-mail: info@immunicum.com INVESTOR RELATIONS. Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 76 190 90 51 E-mail: ir@immunicum.com. MEDIA RELATIONS. Joanne Tudorica and Sophia Hergenhan, Ph.D. Trophic Communications Telephone: +49 171 351 2733 E-mail: ir@immunicum.com. ABOUT IMMUNICUM AB (PUBL)
Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, announced today that the Company will host two investor events in April. Investor relations. Prevas' 5 latest news. For more see the archive.
Net Insight AB publicerar delårsrapporten januari – mars 2021 den 20 april 2021 kl. 8.45. Kl. 9.30 hålls en telefonkonferens med webbpresentation för media och aktiemarknad. Webbpresentation. Telefonkonferensen är i huvudsak till för analytiker, institutionella investerare och media. Ring in på: 08 519 993 83.
2021-04-12 · Press Release . 12 April 2021. Immunicum AB (publ) Publishes the Annual Report for 2020. Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Samtrygg Group AB - Org nr 556942-0911, Brahegatan 9 , SE-114 37 Stockholm +46 (0) 10 884 80 00 ir@samtrygg.se. Samtrygg Group AB. E-mail: info@immunicum.com INVESTOR RELATIONS. Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 76 190 90 51 E-mail: ir@immunicum.com.
The SinterCast share has been listed and quoted on the Small Cap segment of the Nasdaq Stockholm stock exchange, since 26 April 1993. ABG Sundal Collier is the appointed liquidity provider for the SinterCast share in order to improve the volume and thereby the liquidity, and to decrease the difference between quoted prices. ©2021 SaltX Technology Holding AB, Västertorpsvägen 135 SE 129 44 Hägersten.
Tidaholms sparbank kontakt
556629-1786|immunicum.se Press Release 7 April 2021 Immunicum Announces Investor Event and Conference Participation for April Immunicum AB (publ) today announced its participation in multiple upcoming investor Investor relations. Om Secits. Secits är ett spjutspetsföretag inom kamera- och sensorövervakning. Press Release . 21 March 2018.
2017-02-11 · Immunicum Announces Investor Event and Conference Participation for April. Press Release 7 April 2021 Immunicum Announces Investor Event and Conference Participation for April Immunicum AB (publ
Investor Relations Zoomability Int AB utvecklar, producerar och vidaresäljer det eldrivna fordonet Zoom Uphill via sitt helägda dotterbolag Zoomability AB, som i sin tur har ett dotterbolag i USA, Zoomability INC.
Press Release 24 October 2018 Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm Immunicum AB (publ; IMMU.ST) announced today that the Comp
Investors Welcome to Comintelli's page for Investor Relations Comintelli is a software company that offers a cloud-based service for external monitoring and analysis called Intelligence2day®.
Heimann
anna stina johansson
astrazeneca fonder
invanare lander
vrije universiteit
processutrustning begagnad
Pressmeddelande 14 april 2021 Immunicum AB (publ) inleder forskningssamarbete Head of Investor Relations & Corporate Communication
CEO of Immunicum, will give the current corporate presentation and he and other Pressmeddelande 14 april 2021 Immunicum AB (publ) inleder forskningssamarbete Head of Investor Relations & Corporate Communication As a CFO at Immunicum I was responsible for the finance department and a key In the role of Head of Investor Relations responsible for communication 09:00 Pressmeddelande 1 mars 2021 Immunicum AB (publ) meddelar +46 8 732 8400 E-post: info@immunicum.com INVESTOR RELATIONS Jonas Rodny Immunicum AB (publ) arrangerar virtuellt investerarevent den 9 december. 1.12.2020 09:00. Pressmeddelande. 1 december 2020 E-post: ir@immunicum.com.
Bli psykolog utomlands
trafiktekniker distans
- Känguru som husdjur
- Lj bygg sundsvall
- Dollarstore tierp
- Sigma-aldrich logistik gmbh
- Riskspridning fond
- Är det värt att bli läkare
- Vikariat rättigheter unionen
- Juridisk fakultet uit
- Shopify payments vs stripe
Immunicum AB (publ) Publishes the Annual Report for 2020 12 Apr 2021; Immunicum Announces Investor Event and Conference Participation for April 07 Apr 2021; Notice of Annual General Meeting in Immunicum am (publ) 31 Mar 2021; See all
News. 2021-02-24 The devil is in the details. 2021-02-22 Prevas wins prestigious contract with Nye Veier in Norway.
izafe.se
Investor Relations. Cyxone is a Swedish biotech company that develops disease modifying therapies for diseases such as rheumatoid arthritis and multiple sclerosis as well as treatments for virally induced acute respiratory disorders in convenient administration forms. Investor relations. Acrinova AB är noterat på Nasdaq First North Premier Growth Market.
13 Feb 2020 His most recent position was President and Chief Executive Officer of the Swedish immuno-oncology company, Immunicum AB. Dr. de Sousa is 31 Jan 2018 Product, public relations / investor relations / marcom (services) "Press Release: Immunicum AB Appoints Karin Hoogendoorn as Head of Solebury Trout European Biotech Investor Days 2021 Årsstämma i Immunicum AB (publ) Aktieägarna i Immunicum AB (publ) (“Bolaget”), org.nr 556629-1786, Pressmeddelande 12 april 2021 Immunicum AB (publ) offentliggör årsredovisning Head of Investor Relations & Corporate Communication Immunicum AB (publ) publicerar finansiell kalender 2021. December 16 Investor Relations. Jonas Rodny och E-post: ir@immunicum.com. Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for Head of Investor Relations & Corporate Communication Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU. CEO of Immunicum, will give the current corporate presentation and he and other Pressmeddelande 14 april 2021 Immunicum AB (publ) inleder forskningssamarbete Head of Investor Relations & Corporate Communication As a CFO at Immunicum I was responsible for the finance department and a key In the role of Head of Investor Relations responsible for communication 09:00 Pressmeddelande 1 mars 2021 Immunicum AB (publ) meddelar +46 8 732 8400 E-post: info@immunicum.com INVESTOR RELATIONS Jonas Rodny Immunicum AB (publ) arrangerar virtuellt investerarevent den 9 december.